17.10 - P. Fabene, Università di Verona

Condividi su
Data dell'evento: 11/10/2014
seminars_2014

Venerdì 17 ottobre - anticipato alle 13:30
Aula seminari, NICO 

Leuko-vascular interaction as a new player in neuromodulation: insights from experimental epilepsy
Paolo Fabene
Dipartimento di Scienze Neurologiche e del Movimento, Università di Verona

The conventional notion that neurons are exclusively responsible for brain signaling is increasingly challenged by the idea that brain function in fact depends on a complex interplay between neurons, glial cells, vascular endothelium, and immune-related blood cells.

Recent data demonstrates that neuronal activity is profoundly affected by an entire cellular and extracellular ‘orchestra’, the socalled neurovascular unit (NVU). Among the ‘musical instruments’ of this orchestra, there may be molecules long-known in biomedicine as important mediators of inflammatory and immune responses in the organism, as well as non-neuronal cell, e.g. leukocytes.

The seminar will be focussed on the structure and function of the NVU, both in the healthy brain and in pathological conditions, such as the abnormal NVU activation observed in epilepsy.

Ospite: Alessandro Vercelli

download pdf

 

 

Agenda

16 febbraio 2019

Torino - 10th International Meeting STEROIDS and NERVOUS SYSTEM

Since 2001, this meeting represented an important event for basic and clinical researchers working on this emerging scientific topic. We will address state-of-the-art approaches in the field of steroids and nervous system, including behavior, epigenetics, genomic and non-genomic actions, the vitamin D, neurodegenerative and psychiatric disorders, and the interference among endocrine disruptors and steroid signaling.

Ricerca

Identificato un nuovo bersaglio per contrastare la SMA

L’inibizione della proteina JNK rallenta la progressione della malattia che colpisce i motoneuroni ed è la prima causa genetica di morte nell’infanzia. Lo dimostra uno studio pubblicato su Frontiers in Molecular Neuroscience dal nostro gruppo di ricerca guidato da Alessandro Vercelli, in collaborazione con l’Istituto Mario Negri di Milano. Chiarire i meccanismi molecolari alla base della SMA può aprire la strada allo sviluppo di nuove terapie.

24 ottobre 2018